DOI: 10.1634/theoncologist.7-1-46. Adenoviral Gene Therapy

10.1634/theoncologist.7-1-46

Crossref journal-article

Oxford University Press (OUP)

The Oncologist (286)

Abstract

AbstractLearning ObjectivesAfter completing this course, the reader should be able to:Understand the advantages and disadvantages of recombinant adenoviral vectors for gene delivery.Review the current biological strategies employed in clinical trials utilizing adenoviral mediated gene therapy for cancer.Understand modifications that may improve the utility of adenoviral vectors for gene therapy approaches.Access CME test online and receive one hour category 1 credit at CME.TheOncologist.comAs of May 2001, 532 gene therapy protocols had been approved for evaluation in clinical trials; however, only five of those had been evaluated in phase III clinical trials. Among the most commonly used vectors for the delivery of genetic material into human cells are the adenoviruses. Remarkable progress has been made with these vectors in the last decade, but some shortcomings continue to challenge investigators. The newly acquired knowledge of the adenoviral life cycle and the positive outcomes from phase II clinical trials have led to the application of vectors engineered to selectively target tumor tissue under controlled promoters.

Bibliography

Vorburger, S. A., & Hunt, K. K. (2002). Adenoviral Gene Therapy. The Oncologist, 7(1), 46â59.

Authors 2

Stephan A. Vorburger (first)
Kelly K. Hunt (additional)

References 107 Referenced 166

10.1038/ng1095-191 / Nat Genet / Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration by Kay (1995)
10.1128/jvi.69.4.2004-2015.1995 / J Virol / Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses by Yang (1995)
10.4049/jimmunol.155.5.2564 / J Immunol / Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo by Yang (1995)
10.1093/jnci/89.1.21 / J Natl Cancer Inst / Gene therapy for cancer: what have we done and where are we going? by Roth (1997)
10.1038/ng0298-180 / Nat Genet / Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity by Schiedner (1998)
10.1128/JVI.75.11.5222-5229.2001 / J Virol / Biology of E1-deleted adenovirus vectors in nonhuman primate muscle by Zoltick (2001)
10.1016/0958-1669(95)80097-2 / Curr Opin Biotechnol / The use of adenoviral vectors for gene therapy and gene transfer in vivo by Bramson (1995)
10.1006/mthe.2000.0037 / Mol Ther / Evaluation of the biodistribution, persistence, toxicity, and potential of germ-line transmission of a replication-competent human adenovirus following intraprostatic administration in the mouse by Paielli (2000)
10.1111/j.1349-7006.1998.tb00482.x / Jpn J Cancer Res / Adeno-associated virus vector containing the herpes simplex virus thymidine kinase gene causes complete regression of intracerebrally implanted human gliomas in mice, in conjunction with ganciclovir administration by Mizuno (1998)
10.1089/10430349950018904 / Hum Gene Ther / Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapy by Lanuti (1999)
10.1089/hum.1995.6.10-1317 / Hum Gene Ther / Adenovirus-mediated gene therapy in an experimental model of breast cancer metastatic to the brain by Colak (1995)
10.1016/0006-8993(95)00616-X / Brain Res / Adenovirus-mediated gene therapy for experimental spinal cord tumors: tumoricidal efficacy and functional outcome by Colak (1995)
10.1002/jnr.490390417 / J Neurosci Res / Adenovirus-mediated gene therapy of experimental gliomas by Perez-Cruet (1994)
10.1073/pnas.91.8.3054 / Proc Natl Acad Sci USA / Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo by Chen (1994)
10.1006/mthe.2000.0030 / Mol Ther / Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors by Trask (2000)
10.1146/annurev.iy.09.040191.001415 / Annu Rev Immunol / The dendritic cell system and its role in immunogenicity by Steinman (1991)
10.1073/pnas.95.11.6279 / Proc Natl Acad Sci USA / Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells by Gong (1998)
10.1126/science.283.5405.1183 / Science / Reciprocal control of T helper cell and dendritic cell differentiation by Rissoan (1999)
{'key': '2021122211435920900_R19', 'first-page': '148', 'article-title': 'p53 tumor suppressor gene therapy for cancer', 'volume': '13', 'author': 'Roth', 'year': '1999', 'journal-title': 'Oncology (Huntingt)'} / Oncology (Huntingt) / p53 tumor suppressor gene therapy for cancer by Roth (1999)
10.1016/0092-8674(93)90719-7 / Cell / p53-dependent apoptosis modulates the cytotoxicity of anticancer agents by Lowe (1993)
10.1038/362847a0 / Nature / p53 is required for radiation-induced apoptosis in mouse thymocytes by Lowe (1993)
10.1126/science.7973635 / Science / p53 status and the efficacy of cancer therapy in vivo by Lowe (1994)
{'key': '2021122211435920900_R23', 'first-page': '4224', 'article-title': 'Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy', 'volume': '5', 'author': 'Xie', 'year': '1999', 'journal-title': 'Clin Cancer Res'} / Clin Cancer Res / Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy by Xie (1999)
{'key': '2021122211435920900_R24', 'first-page': '4722', 'article-title': 'Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53', 'volume': '57', 'author': 'Hunt', 'year': '1997', 'journal-title': 'Cancer Res'} / Cancer Res / Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53 by Hunt (1997)
10.1089/10430340050015185 / Hum Gene Ther / Adenovirus-mediated transfer of caspase-8 augments cell death in gliomas: implication for gene therapy by Shinoura (2000)
10.1074/jbc.270.14.7795 / J Biol Chem / A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain by Boldin (1995)
10.1016/S0022-5223(96)70154-X / J Thorac Cardiovasc Surg / Gene therapy for lung cancer: enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirusmediated p53 gene transfer by Nguyen (1996)
{'key': '2021122211435920900_R28', 'first-page': '855', 'article-title': 'Combination therapy of adenovirus-mediated overexpression of E2F-1 transcription factor and chemotherapy enhances growth suppression in breast cancer cells', 'volume': '42', 'author': 'Yoshida', 'year': '2001', 'journal-title': 'Proc Am Assoc Cancer Res'} / Proc Am Assoc Cancer Res / Combination therapy of adenovirus-mediated overexpression of E2F-1 transcription factor and chemotherapy enhances growth suppression in breast cancer cells by Yoshida (2001)
10.1089/hum.1996.7.14-1727 / Hum Gene Ther / Ionizing radiation greatly improves gene transfer efficiency in mammalian cells by Stevens (1996)
10.1038/78638 / Nat Med / A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer by Khuri (2000)
{'key': '2021122211435920900_R31', 'article-title': 'Suicide gene therapy: a phase I study of E1B-attenuated replication-competent adenovirus vector-mediated intratumoral administration of the E', 'volume-title': 'coli cytosin deaminase/HSV-1 thymidine kinase fusion gene in conjunction with two prodrugs, 5-fluorocytosin and ganciclovir, for patients with local recurrence of prostate cancer after radiation therapy', 'author': 'Kim', 'year': '1999'} / coli cytosin deaminase/HSV-1 thymidine kinase fusion gene in conjunction with two prodrugs, 5-fluorocytosin and ganciclovir, for patients with local recurrence of prostate cancer after radiation therapy / Suicide gene therapy: a phase I study of E1B-attenuated replication-competent adenovirus vector-mediated intratumoral administration of the E by Kim (1999)
10.1038/2000 / Nat Med / Killing tumor cells with viruses—a question of specificity by Lane (1998)
{'key': '2021122211435920900_R33', 'first-page': '4369', 'article-title': 'p53 selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinoma', 'volume': '59', 'author': 'Vollmer', 'year': '1999', 'journal-title': 'Cancer Res'} / Cancer Res / p53 selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinoma by Vollmer (1999)
10.1128/JVI.74.6.2895-2899.2000 / J Virol / Productive replication of human adenoviruses in mouse epidermal cells by Ganly (2000)
10.1016/S0140-6736(05)73358-4 / Lancet / Crisis of adenoviruses in human gene therapy by Teramato (2000)
10.1001/jama.285.20.2570-JMN0523-3-1 / JAMA / Studies illuminate cause of fatal reaction in gene-therapy trial by Stephenson (2001)
10.1016/S0169-409X(00)00125-3 / Adv Drug Deliv Rev / Adenovirus-mediated gene transfer to liver by Wilson (2001)
10.1016/0042-6822(87)90441-7 / Virology / Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection by Barker (1987)
10.1038/nm0697-639 / Nat Med / ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents by Heise (1997)
10.1038/nm0697-606 / Nat Med / Progress of the smart bomb cancer virus by Lowe (1997)
10.1089/10430340150218369 / Hum Gene Ther / E1B-deleted adenovirus (dl1520) gene therapy for patients with primary and secondary liver tumors by Habib (2001)
{'key': '2021122211435920900_R42', 'first-page': '2666', 'article-title': 'Efficient induction of cell death by adenoviruses requires binding of E1B55k and p53', 'volume': '60', 'author': 'Dix', 'year': '2000', 'journal-title': 'Cancer Res'} / Cancer Res / Efficient induction of cell death by adenoviruses requires binding of E1B55k and p53 by Dix (2000)
10.1128/JVI.72.12.9470-9478.1998 / J Virol / Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells by Rothmann (1998)
{'key': '2021122211435920900_R44', 'first-page': '813', 'article-title': 'Efficient oncolysis by a replicating adenovirus (ad) in vivo is critically dependent on tumor expression of primary ad receptors', 'volume': '61', 'author': 'Douglas', 'year': '2001', 'journal-title': 'Cancer Res'} / Cancer Res / Efficient oncolysis by a replicating adenovirus (ad) in vivo is critically dependent on tumor expression of primary ad receptors by Douglas (2001)
10.1073/pnas.95.14.7866 / Proc Natl Acad Sci USA / An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene by Morsy (1998)
10.1128/jvi.71.3.1842-1849.1997 / J Virol / Construction of adenovirus vectors through Cre-lox recombination by Hardy (1997)
10.1016/S1357-4310(98)01376-8 / Mol Med Today / Expanded-capacity adenoviral vectors—the helper-dependent vectors by Morsy (1999)
10.1128/JVI.72.2.926-933.1998 / J Virol / Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted by Amalfitano (1998)
10.1073/pnas.96.22.12816 / Proc Natl Acad Sci USA / Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons by Morral (1999)
10.1182/blood.V95.3.820.003k32_820_828 / Blood / Sustained high-level expression of full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector by Balague (2000)
10.1089/hum.1998.9.18-2709 / Hum Gene Ther / High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha1-antitrypsin with negligible toxicity by Morral (1998)
10.1089/hum.1998.9.18-2745 / Hum Gene Ther / Novel tools for production and purification of recombinant adenoassociated virus vectors by Grimm (1998)
10.1128/jvi.71.2.1341-1352.1997 / J Virol / Subcellular compartmentalization of adeno-associated virus type 2 assembly by Wistuba (1997)
10.1038/sj.gt.3300938 / Gene Ther / Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield by Zolotukhin (1999)
10.1016/S0958-1669(00)00080-X / Curr Opin Biotechnol / Production of viral vectors for gene therapy applications by Wu (2000)
10.1089/hum.1996.7.17-2079 / Hum Gene Ther / A novel adenovirus-adeno-associated virus hybrid vector that displays efficient rescue and delivery of the AAV genome by Fisher (1996)
10.1096/fasebj.11.8.9240964 / FASEB J / Adenoviral/retroviral vector chimeras: a novel strategy to achieve high-efficiency stable transduction in vivo by Bilbao (1997)
10.1089/10430349950018986 / Hum Gene Ther / Functional characterization of adenoviral/retroviral chimeric vectors and their use for efficient screening of retroviral producer cell lines by Duisit (1999)
10.1126/science.275.5304.1320 / Science / Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5 by Bergelson (1997)
10.1038/sj.gt.3301038 / Gene Ther / Considerations and challenges for the achievement of targeted gene delivery by Curiel (1999)
10.1016/0092-8674(93)90231-E / Cell / Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment by Wickham (1993)
10.1074/jbc.274.15.10219 / J Biol Chem / Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia by Walters (1999)
10.1038/nbt1196-1570 / Nat Biotechnol / Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types by Wickham (1996)
10.1128/jvi.70.10.6831-6838.1996 / J Virol / Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies by Wickham (1996)
10.1128/jvi.71.11.8221-8229.1997 / J Virol / Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins by Wickham (1997)
10.1038/sj.cgt.7700174 / Cancer Gene Ther / Adenovirus as a gene therapy vector for hematopoietic cells by Marini FC (2000)
10.1126/science.286.5444.1568 / Science / Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae by Roelvink (1999)
{'key': '2021122211435920900_R68', 'first-page': '660', 'article-title': 'Addition of a short peptide ligand to the adenovirus fiber protein', 'volume': '2', 'author': 'Michael', 'year': '1995', 'journal-title': 'Gene Ther'} / Gene Ther / Addition of a short peptide ligand to the adenovirus fiber protein by Michael (1995)
10.1128/JVI.73.2.1601-1608.1999 / J Virol / A helper-independent adenovirus vector with E1, E3, and fiber deleted: structure and infectivity of fiberless particles by Seggern (1999)
10.1128/JVI.74.15.6875-6884.2000 / J Virol / Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells by Dmitriev (2000)
10.1128/jvi.70.7.4502-4508.1996 / J Virol / Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells by Huang (1996)
10.1128/JVI.72.12.9706-9713.1998 / J Virol / An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism by Dmitriev (1998)
{'key': '2021122211435920900_R73', 'first-page': '2571', 'article-title': 'Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector', 'volume': '5', 'author': 'Kasono', 'year': '1999', 'journal-title': 'Clin Cancer Res'} / Clin Cancer Res / Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector by Kasono (1999)
10.1006/gyno.1999.5432 / Gynecol Oncol / An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches by Vanderkwaak (1999)
10.1038/sj.cgt.7700074 / Cancer Gene Ther / Polycations and cationic lipids enhance adenovirus transduction and transgene expression in tumor cells by Clark (1999)
10.1089/10430349950017554 / Hum Gene Ther / Recombinant adenoviral vector-lipofectAMINE complex for gene transduction into human T lymphocytes by Di Nicola (1999)
10.1038/sj.gt.3300987 / Gene Ther / Use of protamine to augment adenovirus-mediated cancer gene therapy by Lanuti (1999)
10.1111/j.1749-6632.1999.tb09409.x / Ann N Y Acad Sci / Strategies to adapt adenoviral vectors for targeted delivery by Curiel (1999)
10.1038/sj.gt.3301115 / Gene Ther / Targeting adenovirus by Wickham (2000)
10.1038/sj.gt.3300995 / Gene Ther / Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration by Parks (1999)
10.1089/hum.1995.6.7-881 / Hum Gene Ther / Transcriptional regulatory sequences of carcinoembryonic antigen: identification and use with cytosine deaminase for tumor-specific gene therapy by Richards (1995)
{'key': '2021122211435920900_R82', 'first-page': '2136', 'article-title': 'Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines', 'volume': '59', 'author': 'Spitzweg', 'year': '1999', 'journal-title': 'Cancer Res'} / Cancer Res / Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines by Spitzweg (1999)
10.1073/pnas.89.21.10149 / Proc Natl Acad Sci USA / Ionizing radiation activates transcription of the EGR1 gene via CArG elements by Datta (1992)
{'key': '2021122211435920900_R84', 'first-page': '4266', 'article-title': 'Gene therapy targeted by radiation preferentially radiosensitizes tumor cells', 'volume': '54', 'author': 'Weichselbaum', 'year': '1994', 'journal-title': 'Cancer Res'} / Cancer Res / Gene therapy targeted by radiation preferentially radiosensitizes tumor cells by Weichselbaum (1994)
10.1016/S0360-3016(00)00788-4 / Int J Radiat Oncol Biol Phys / Enhancement of radiotherapy by hyperthermia-regulated gene therapy by Lohr (2000)
10.1038/sj.gt.3301296 / Gene Ther / Transcriptionally active drugs improve adenovirus vector performance in vitro and in vivo by Gaetano (2000)
10.1016/S0959-437X(99)80022-7 / Curr Opin Genet Dev / Chromatin-modifying and -remodeling complexes by Kornberg (1999)
10.1016/S0959-437X(99)80021-5 / Curr Opin Genet Dev / Coactivator and corepressor complexes in nuclear receptor function by Xu (1999)
10.1128/jvi.68.7.4241-4250.1994 / J Virol / Characterization of replication-competent retroviruses from nonhuman primates with virus-induced T-cell lymphomas and observations regarding the mechanism of oncogenesis by Vanin (1994)
10.1089/10430340050015536 / Hum Gene Ther / Human gene marker/therapy clinical protocols by Rosenberg (2000)
{'key': '2021122211435920900_R91', 'first-page': '4239', 'article-title': 'Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection', 'volume': '10', 'author': 'Miller', 'year': '1990', 'journal-title': 'Mol Cell Biol'} / Mol Cell Biol / Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection by Miller (1990)
10.1126/science.276.5319.1719 / Science / HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia by Bonini (1997)
10.1006/mthe.2000.0225 / Mol Ther / Herpesvirus-mediated systemic delivery of nerve growth factor by Wolfe (2001)
10.1016/S1359-6446(01)01713-5 / Drug Discov Today / Multi-modal combination gene therapy for malignant glioma using replication-defective HSV vectors by Burton (2001)
10.1006/exnr.1999.7158 / Exp Neurol / Engineering herpes simplex virus vectors for CNS applications by Wolfe (1999)
10.1073/pnas.96.7.4078 / Proc Natl Acad Sci USA / Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo by Yamada (1999)
10.1016/S0076-6879(00)16760-6 / Methods Enzymol / Production and purification of recombinant adeno-associated virus by Hauswirth (2000)
10.1089/10430349950018427 / Hum Gene Ther / Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses by Clark (1999)
10.1038/sj.gt.3300807 / Gene Ther / Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus by Liu (1999)
10.1073/pnas.97.12.6716 / Proc Natl Acad Sci USA / Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy by Yan (2000)
10.1038/75087 / Nat Med / Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization by Sun (2000)
10.1097/00005537-199902000-00017 / Laryngoscope / Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus by Wagner (1999)
10.1128/JVI.73.9.7812-7816.1999 / J Virol / Rescue from photoreceptor degeneration in the rd mouse by human immunodeficiency virus vector-mediated gene transfer by Takahashi (1999)
10.1038/71673 / Nat Genet / Efficient lentiviral transduction of liver requires cell cycling in vivo by Park (2000)
10.1182/blood.V96.3.1173.015k34_1173_1176 / Blood / Therapeutic levels of human factor VIII and IX using HIV-1-based lentiviral vectors in mouse liver by Park (2000)
10.1038/ng1197-314 / Nat Genet / Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors by Kafri (1997)
10.1128/jvi.71.9.6641-6649.1997 / J Virol / Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector by Blomer (1997)

Dates

Type	When
Created	21 years ago (Aug. 24, 2004, 5:38 p.m.)
Deposited	8 months, 2 weeks ago (Dec. 18, 2024, 5:36 a.m.)
Indexed	1 month ago (Aug. 6, 2025, 8:31 a.m.)
Issued	23 years, 7 months ago (Feb. 1, 2002)
Published	23 years, 7 months ago (Feb. 1, 2002)
Published Online	23 years, 7 months ago (Feb. 1, 2002)
Published Print	23 years, 7 months ago (Feb. 1, 2002)

Funders 0

None

BibTeX

@article{Vorburger_2002, title={Adenoviral Gene Therapy}, volume={7}, ISSN={1549-490X}, url={http://dx.doi.org/10.1634/theoncologist.7-1-46}, DOI={10.1634/theoncologist.7-1-46}, number={1}, journal={The Oncologist}, publisher={Oxford University Press (OUP)}, author={Vorburger, Stephan A. and Hunt, Kelly K.}, year={2002}, month=feb, pages={46–59} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        8,
        6
      ]
    ],
    "date-time": "2025-08-06T12:31:54Z",
    "timestamp": 1754483514217,
    "version": "3.30.2"
  },
  "reference-count": 107,
  "publisher": "Oxford University Press (OUP)",
  "issue": "1",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2002,
            2,
            1
          ]
        ],
        "date-time": "2002-02-01T00:00:00Z",
        "timestamp": 1012521600000
      },
      "content-version": "vor",
      "delay-in-days": 0,
      "URL": "https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2002,
        2,
        1
      ]
    ]
  },
  "abstract": "<jats:title>Abstract</jats:title><jats:sec><jats:title>Learning Objectives</jats:title><jats:p>After completing this course, the reader should be able to:Understand the advantages and disadvantages of recombinant adenoviral vectors for gene delivery.Review the current biological strategies employed in clinical trials utilizing adenoviral mediated gene therapy for cancer.Understand modifications that may improve the utility of adenoviral vectors for gene therapy approaches.</jats:p><jats:p>Access CME test online and receive one hour category 1 credit at CME.TheOncologist.com</jats:p><jats:p>As of May 2001, 532 gene therapy protocols had been approved for evaluation in clinical trials; however, only five of those had been evaluated in phase III clinical trials. Among the most commonly used vectors for the delivery of genetic material into human cells are the adenoviruses. Remarkable progress has been made with these vectors in the last decade, but some shortcomings continue to challenge investigators. The newly acquired knowledge of the adenoviral life cycle and the positive outcomes from phase II clinical trials have led to the application of vectors engineered to selectively target tumor tissue under controlled promoters.</jats:p></jats:sec>",
  "DOI": "10.1634/theoncologist.7-1-46",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2004,
        8,
        24
      ]
    ],
    "date-time": "2004-08-24T21:38:39Z",
    "timestamp": 1093383519000
  },
  "page": "46-59",
  "source": "Crossref",
  "is-referenced-by-count": 166,
  "title": "Adenoviral Gene Therapy",
  "prefix": "10.1093",
  "volume": "7",
  "author": [
    {
      "given": "Stephan A.",
      "family": "Vorburger",
      "sequence": "first",
      "affiliation": [
        {
          "name": "Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA"
        }
      ]
    },
    {
      "given": "Kelly K.",
      "family": "Hunt",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA"
        }
      ]
    }
  ],
  "member": "286",
  "published-online": {
    "date-parts": [
      [
        2002,
        2,
        1
      ]
    ]
  },
  "reference": [
    {
      "key": "2021122211435920900_R1",
      "doi-asserted-by": "crossref",
      "first-page": "191",
      "DOI": "10.1038/ng1095-191",
      "article-title": "Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration",
      "volume": "11",
      "author": "Kay",
      "year": "1995",
      "journal-title": "Nat Genet"
    },
    {
      "key": "2021122211435920900_R2",
      "doi-asserted-by": "crossref",
      "first-page": "2004",
      "DOI": "10.1128/jvi.69.4.2004-2015.1995",
      "article-title": "Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses",
      "volume": "69",
      "author": "Yang",
      "year": "1995",
      "journal-title": "J Virol"
    },
    {
      "key": "2021122211435920900_R3",
      "doi-asserted-by": "crossref",
      "first-page": "2564",
      "DOI": "10.4049/jimmunol.155.5.2564",
      "article-title": "Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo",
      "volume": "155",
      "author": "Yang",
      "year": "1995",
      "journal-title": "J Immunol"
    },
    {
      "key": "2021122211435920900_R4",
      "doi-asserted-by": "crossref",
      "first-page": "21",
      "DOI": "10.1093/jnci/89.1.21",
      "article-title": "Gene therapy for cancer: what have we done and where are we going?",
      "volume": "89",
      "author": "Roth",
      "year": "1997",
      "journal-title": "J Natl Cancer Inst"
    },
    {
      "key": "2021122211435920900_R5",
      "doi-asserted-by": "crossref",
      "first-page": "180",
      "DOI": "10.1038/ng0298-180",
      "article-title": "Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity",
      "volume": "18",
      "author": "Schiedner",
      "year": "1998",
      "journal-title": "Nat Genet"
    },
    {
      "key": "2021122211435920900_R6",
      "doi-asserted-by": "crossref",
      "first-page": "5222",
      "DOI": "10.1128/JVI.75.11.5222-5229.2001",
      "article-title": "Biology of E1-deleted adenovirus vectors in nonhuman primate muscle",
      "volume": "75",
      "author": "Zoltick",
      "year": "2001",
      "journal-title": "J Virol"
    },
    {
      "key": "2021122211435920900_R7",
      "doi-asserted-by": "crossref",
      "first-page": "590",
      "DOI": "10.1016/0958-1669(95)80097-2",
      "article-title": "The use of adenoviral vectors for gene therapy and gene transfer in vivo",
      "volume": "6",
      "author": "Bramson",
      "year": "1995",
      "journal-title": "Curr Opin Biotechnol"
    },
    {
      "key": "2021122211435920900_R8",
      "doi-asserted-by": "crossref",
      "first-page": "263",
      "DOI": "10.1006/mthe.2000.0037",
      "article-title": "Evaluation of the biodistribution, persistence, toxicity, and potential of germ-line transmission of a replication-competent human adenovirus following intraprostatic administration in the mouse",
      "volume": "1",
      "author": "Paielli",
      "year": "2000",
      "journal-title": "Mol Ther"
    },
    {
      "key": "2021122211435920900_R9",
      "doi-asserted-by": "crossref",
      "first-page": "76",
      "DOI": "10.1111/j.1349-7006.1998.tb00482.x",
      "article-title": "Adeno-associated virus vector containing the herpes simplex virus thymidine kinase gene causes complete regression of intracerebrally implanted human gliomas in mice, in conjunction with ganciclovir administration",
      "volume": "89",
      "author": "Mizuno",
      "year": "1998",
      "journal-title": "Jpn J Cancer Res"
    },
    {
      "key": "2021122211435920900_R10",
      "doi-asserted-by": "crossref",
      "first-page": "463",
      "DOI": "10.1089/10430349950018904",
      "article-title": "Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapy",
      "volume": "10",
      "author": "Lanuti",
      "year": "1999",
      "journal-title": "Hum Gene Ther"
    },
    {
      "key": "2021122211435920900_R11",
      "doi-asserted-by": "crossref",
      "first-page": "1317",
      "DOI": "10.1089/hum.1995.6.10-1317",
      "article-title": "Adenovirus-mediated gene therapy in an experimental model of breast cancer metastatic to the brain",
      "volume": "6",
      "author": "Colak",
      "year": "1995",
      "journal-title": "Hum Gene Ther"
    },
    {
      "key": "2021122211435920900_R12",
      "doi-asserted-by": "crossref",
      "first-page": "76",
      "DOI": "10.1016/0006-8993(95)00616-X",
      "article-title": "Adenovirus-mediated gene therapy for experimental spinal cord tumors: tumoricidal efficacy and functional outcome",
      "volume": "691",
      "author": "Colak",
      "year": "1995",
      "journal-title": "Brain Res"
    },
    {
      "key": "2021122211435920900_R13",
      "doi-asserted-by": "crossref",
      "first-page": "506",
      "DOI": "10.1002/jnr.490390417",
      "article-title": "Adenovirus-mediated gene therapy of experimental gliomas",
      "volume": "39",
      "author": "Perez-Cruet",
      "year": "1994",
      "journal-title": "J Neurosci Res"
    },
    {
      "key": "2021122211435920900_R14",
      "doi-asserted-by": "crossref",
      "first-page": "3054",
      "DOI": "10.1073/pnas.91.8.3054",
      "article-title": "Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo",
      "volume": "91",
      "author": "Chen",
      "year": "1994",
      "journal-title": "Proc Natl Acad Sci USA"
    },
    {
      "key": "2021122211435920900_R15",
      "doi-asserted-by": "crossref",
      "first-page": "195",
      "DOI": "10.1006/mthe.2000.0030",
      "article-title": "Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors",
      "volume": "1",
      "author": "Trask",
      "year": "2000",
      "journal-title": "Mol Ther"
    },
    {
      "key": "2021122211435920900_R16",
      "doi-asserted-by": "crossref",
      "first-page": "271",
      "DOI": "10.1146/annurev.iy.09.040191.001415",
      "article-title": "The dendritic cell system and its role in immunogenicity",
      "volume": "9",
      "author": "Steinman",
      "year": "1991",
      "journal-title": "Annu Rev Immunol"
    },
    {
      "key": "2021122211435920900_R17",
      "doi-asserted-by": "crossref",
      "first-page": "6279",
      "DOI": "10.1073/pnas.95.11.6279",
      "article-title": "Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells",
      "volume": "95",
      "author": "Gong",
      "year": "1998",
      "journal-title": "Proc Natl Acad Sci USA"
    },
    {
      "key": "2021122211435920900_R18",
      "doi-asserted-by": "crossref",
      "first-page": "1183",
      "DOI": "10.1126/science.283.5405.1183",
      "article-title": "Reciprocal control of T helper cell and dendritic cell differentiation",
      "volume": "283",
      "author": "Rissoan",
      "year": "1999",
      "journal-title": "Science"
    },
    {
      "key": "2021122211435920900_R19",
      "first-page": "148",
      "article-title": "p53 tumor suppressor gene therapy for cancer",
      "volume": "13",
      "author": "Roth",
      "year": "1999",
      "journal-title": "Oncology (Huntingt)"
    },
    {
      "key": "2021122211435920900_R20",
      "doi-asserted-by": "crossref",
      "first-page": "957",
      "DOI": "10.1016/0092-8674(93)90719-7",
      "article-title": "p53-dependent apoptosis modulates the cytotoxicity of anticancer agents",
      "volume": "74",
      "author": "Lowe",
      "year": "1993",
      "journal-title": "Cell"
    },
    {
      "key": "2021122211435920900_R21",
      "doi-asserted-by": "crossref",
      "first-page": "847",
      "DOI": "10.1038/362847a0",
      "article-title": "p53 is required for radiation-induced apoptosis in mouse thymocytes",
      "volume": "362",
      "author": "Lowe",
      "year": "1993",
      "journal-title": "Nature"
    },
    {
      "key": "2021122211435920900_R22",
      "doi-asserted-by": "crossref",
      "first-page": "807",
      "DOI": "10.1126/science.7973635",
      "article-title": "p53 status and the efficacy of cancer therapy in vivo",
      "volume": "266",
      "author": "Lowe",
      "year": "1994",
      "journal-title": "Science"
    },
    {
      "key": "2021122211435920900_R23",
      "first-page": "4224",
      "article-title": "Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy",
      "volume": "5",
      "author": "Xie",
      "year": "1999",
      "journal-title": "Clin Cancer Res"
    },
    {
      "key": "2021122211435920900_R24",
      "first-page": "4722",
      "article-title": "Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53",
      "volume": "57",
      "author": "Hunt",
      "year": "1997",
      "journal-title": "Cancer Res"
    },
    {
      "key": "2021122211435920900_R25",
      "doi-asserted-by": "crossref",
      "first-page": "1123",
      "DOI": "10.1089/10430340050015185",
      "article-title": "Adenovirus-mediated transfer of caspase-8 augments cell death in gliomas: implication for gene therapy",
      "volume": "11",
      "author": "Shinoura",
      "year": "2000",
      "journal-title": "Hum Gene Ther"
    },
    {
      "key": "2021122211435920900_R26",
      "doi-asserted-by": "crossref",
      "first-page": "7795",
      "DOI": "10.1074/jbc.270.14.7795",
      "article-title": "A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain",
      "volume": "270",
      "author": "Boldin",
      "year": "1995",
      "journal-title": "J Biol Chem"
    },
    {
      "key": "2021122211435920900_R27",
      "doi-asserted-by": "crossref",
      "first-page": "1372",
      "DOI": "10.1016/S0022-5223(96)70154-X",
      "article-title": "Gene therapy for lung cancer: enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirusmediated p53 gene transfer",
      "volume": "112",
      "author": "Nguyen",
      "year": "1996",
      "journal-title": "J Thorac Cardiovasc Surg"
    },
    {
      "key": "2021122211435920900_R28",
      "first-page": "855",
      "article-title": "Combination therapy of adenovirus-mediated overexpression of E2F-1 transcription factor and chemotherapy enhances growth suppression in breast cancer cells",
      "volume": "42",
      "author": "Yoshida",
      "year": "2001",
      "journal-title": "Proc Am Assoc Cancer Res"
    },
    {
      "key": "2021122211435920900_R29",
      "doi-asserted-by": "crossref",
      "first-page": "1727",
      "DOI": "10.1089/hum.1996.7.14-1727",
      "article-title": "Ionizing radiation greatly improves gene transfer efficiency in mammalian cells",
      "volume": "7",
      "author": "Stevens",
      "year": "1996",
      "journal-title": "Hum Gene Ther"
    },
    {
      "key": "2021122211435920900_R30",
      "doi-asserted-by": "crossref",
      "first-page": "879",
      "DOI": "10.1038/78638",
      "article-title": "A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer",
      "volume": "6",
      "author": "Khuri",
      "year": "2000",
      "journal-title": "Nat Med"
    },
    {
      "key": "2021122211435920900_R31",
      "article-title": "Suicide gene therapy: a phase I study of E1B-attenuated replication-competent adenovirus vector-mediated intratumoral administration of the E",
      "volume-title": "coli cytosin deaminase/HSV-1 thymidine kinase fusion gene in conjunction with two prodrugs, 5-fluorocytosin and ganciclovir, for patients with local recurrence of prostate cancer after radiation therapy",
      "author": "Kim",
      "year": "1999"
    },
    {
      "key": "2021122211435920900_R32",
      "doi-asserted-by": "crossref",
      "first-page": "1012",
      "DOI": "10.1038/2000",
      "article-title": "Killing tumor cells with viruses\u2014a question of specificity",
      "volume": "4",
      "author": "Lane",
      "year": "1998",
      "journal-title": "Nat Med"
    },
    {
      "key": "2021122211435920900_R33",
      "first-page": "4369",
      "article-title": "p53 selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinoma",
      "volume": "59",
      "author": "Vollmer",
      "year": "1999",
      "journal-title": "Cancer Res"
    },
    {
      "key": "2021122211435920900_R34",
      "doi-asserted-by": "crossref",
      "first-page": "2895",
      "DOI": "10.1128/JVI.74.6.2895-2899.2000",
      "article-title": "Productive replication of human adenoviruses in mouse epidermal cells",
      "volume": "74",
      "author": "Ganly",
      "year": "2000",
      "journal-title": "J Virol"
    },
    {
      "key": "2021122211435920900_R35",
      "doi-asserted-by": "crossref",
      "first-page": "1911",
      "DOI": "10.1016/S0140-6736(05)73358-4",
      "article-title": "Crisis of adenoviruses in human gene therapy",
      "volume": "355",
      "author": "Teramato",
      "year": "2000",
      "journal-title": "Lancet"
    },
    {
      "key": "2021122211435920900_R36",
      "doi-asserted-by": "crossref",
      "first-page": "2570",
      "DOI": "10.1001/jama.285.20.2570-JMN0523-3-1",
      "article-title": "Studies illuminate cause of fatal reaction in gene-therapy trial",
      "volume": "285",
      "author": "Stephenson",
      "year": "2001",
      "journal-title": "JAMA"
    },
    {
      "key": "2021122211435920900_R37",
      "doi-asserted-by": "crossref",
      "first-page": "205",
      "DOI": "10.1016/S0169-409X(00)00125-3",
      "article-title": "Adenovirus-mediated gene transfer to liver",
      "volume": "46",
      "author": "Wilson",
      "year": "2001",
      "journal-title": "Adv Drug Deliv Rev"
    },
    {
      "key": "2021122211435920900_R38",
      "doi-asserted-by": "crossref",
      "first-page": "107",
      "DOI": "10.1016/0042-6822(87)90441-7",
      "article-title": "Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection",
      "volume": "156",
      "author": "Barker",
      "year": "1987",
      "journal-title": "Virology"
    },
    {
      "key": "2021122211435920900_R39",
      "doi-asserted-by": "crossref",
      "first-page": "639",
      "DOI": "10.1038/nm0697-639",
      "article-title": "ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents",
      "volume": "3",
      "author": "Heise",
      "year": "1997",
      "journal-title": "Nat Med"
    },
    {
      "key": "2021122211435920900_R40",
      "doi-asserted-by": "crossref",
      "first-page": "606",
      "DOI": "10.1038/nm0697-606",
      "article-title": "Progress of the smart bomb cancer virus",
      "volume": "3",
      "author": "Lowe",
      "year": "1997",
      "journal-title": "Nat Med"
    },
    {
      "key": "2021122211435920900_R41",
      "doi-asserted-by": "crossref",
      "first-page": "219",
      "DOI": "10.1089/10430340150218369",
      "article-title": "E1B-deleted adenovirus (dl1520) gene therapy for patients with primary and secondary liver tumors",
      "volume": "12",
      "author": "Habib",
      "year": "2001",
      "journal-title": "Hum Gene Ther"
    },
    {
      "key": "2021122211435920900_R42",
      "first-page": "2666",
      "article-title": "Efficient induction of cell death by adenoviruses requires binding of E1B55k and p53",
      "volume": "60",
      "author": "Dix",
      "year": "2000",
      "journal-title": "Cancer Res"
    },
    {
      "key": "2021122211435920900_R43",
      "doi-asserted-by": "crossref",
      "first-page": "9470",
      "DOI": "10.1128/JVI.72.12.9470-9478.1998",
      "article-title": "Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells",
      "volume": "72",
      "author": "Rothmann",
      "year": "1998",
      "journal-title": "J Virol"
    },
    {
      "key": "2021122211435920900_R44",
      "first-page": "813",
      "article-title": "Efficient oncolysis by a replicating adenovirus (ad) in vivo is critically dependent on tumor expression of primary ad receptors",
      "volume": "61",
      "author": "Douglas",
      "year": "2001",
      "journal-title": "Cancer Res"
    },
    {
      "key": "2021122211435920900_R45",
      "doi-asserted-by": "crossref",
      "first-page": "7866",
      "DOI": "10.1073/pnas.95.14.7866",
      "article-title": "An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene",
      "volume": "95",
      "author": "Morsy",
      "year": "1998",
      "journal-title": "Proc Natl Acad Sci USA"
    },
    {
      "key": "2021122211435920900_R46",
      "doi-asserted-by": "crossref",
      "first-page": "1842",
      "DOI": "10.1128/jvi.71.3.1842-1849.1997",
      "article-title": "Construction of adenovirus vectors through Cre-lox recombination",
      "volume": "71",
      "author": "Hardy",
      "year": "1997",
      "journal-title": "J Virol"
    },
    {
      "key": "2021122211435920900_R47",
      "doi-asserted-by": "crossref",
      "first-page": "18",
      "DOI": "10.1016/S1357-4310(98)01376-8",
      "article-title": "Expanded-capacity adenoviral vectors\u2014the helper-dependent vectors",
      "volume": "5",
      "author": "Morsy",
      "year": "1999",
      "journal-title": "Mol Med Today"
    },
    {
      "key": "2021122211435920900_R48",
      "doi-asserted-by": "crossref",
      "first-page": "926",
      "DOI": "10.1128/JVI.72.2.926-933.1998",
      "article-title": "Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted",
      "volume": "72",
      "author": "Amalfitano",
      "year": "1998",
      "journal-title": "J Virol"
    },
    {
      "key": "2021122211435920900_R49",
      "doi-asserted-by": "crossref",
      "first-page": "12816",
      "DOI": "10.1073/pnas.96.22.12816",
      "article-title": "Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons",
      "volume": "96",
      "author": "Morral",
      "year": "1999",
      "journal-title": "Proc Natl Acad Sci USA"
    },
    {
      "key": "2021122211435920900_R50",
      "doi-asserted-by": "crossref",
      "first-page": "820",
      "DOI": "10.1182/blood.V95.3.820.003k32_820_828",
      "article-title": "Sustained high-level expression of full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector",
      "volume": "95",
      "author": "Balague",
      "year": "2000",
      "journal-title": "Blood"
    },
    {
      "key": "2021122211435920900_R51",
      "doi-asserted-by": "crossref",
      "first-page": "2709",
      "DOI": "10.1089/hum.1998.9.18-2709",
      "article-title": "High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha1-antitrypsin with negligible toxicity",
      "volume": "9",
      "author": "Morral",
      "year": "1998",
      "journal-title": "Hum Gene Ther"
    },
    {
      "key": "2021122211435920900_R52",
      "doi-asserted-by": "crossref",
      "first-page": "2745",
      "DOI": "10.1089/hum.1998.9.18-2745",
      "article-title": "Novel tools for production and purification of recombinant adenoassociated virus vectors",
      "volume": "9",
      "author": "Grimm",
      "year": "1998",
      "journal-title": "Hum Gene Ther"
    },
    {
      "key": "2021122211435920900_R53",
      "doi-asserted-by": "crossref",
      "first-page": "1341",
      "DOI": "10.1128/jvi.71.2.1341-1352.1997",
      "article-title": "Subcellular compartmentalization of adeno-associated virus type 2 assembly",
      "volume": "71",
      "author": "Wistuba",
      "year": "1997",
      "journal-title": "J Virol"
    },
    {
      "key": "2021122211435920900_R54",
      "doi-asserted-by": "crossref",
      "first-page": "973",
      "DOI": "10.1038/sj.gt.3300938",
      "article-title": "Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield",
      "volume": "6",
      "author": "Zolotukhin",
      "year": "1999",
      "journal-title": "Gene Ther"
    },
    {
      "key": "2021122211435920900_R55",
      "doi-asserted-by": "crossref",
      "first-page": "205",
      "DOI": "10.1016/S0958-1669(00)00080-X",
      "article-title": "Production of viral vectors for gene therapy applications",
      "volume": "11",
      "author": "Wu",
      "year": "2000",
      "journal-title": "Curr Opin Biotechnol"
    },
    {
      "key": "2021122211435920900_R56",
      "doi-asserted-by": "crossref",
      "first-page": "2079",
      "DOI": "10.1089/hum.1996.7.17-2079",
      "article-title": "A novel adenovirus-adeno-associated virus hybrid vector that displays efficient rescue and delivery of the AAV genome",
      "volume": "7",
      "author": "Fisher",
      "year": "1996",
      "journal-title": "Hum Gene Ther"
    },
    {
      "key": "2021122211435920900_R57",
      "doi-asserted-by": "crossref",
      "first-page": "624",
      "DOI": "10.1096/fasebj.11.8.9240964",
      "article-title": "Adenoviral/retroviral vector chimeras: a novel strategy to achieve high-efficiency stable transduction in vivo",
      "volume": "11",
      "author": "Bilbao",
      "year": "1997",
      "journal-title": "FASEB J"
    },
    {
      "key": "2021122211435920900_R58",
      "doi-asserted-by": "crossref",
      "first-page": "189",
      "DOI": "10.1089/10430349950018986",
      "article-title": "Functional characterization of adenoviral/retroviral chimeric vectors and their use for efficient screening of retroviral producer cell lines",
      "volume": "10",
      "author": "Duisit",
      "year": "1999",
      "journal-title": "Hum Gene Ther"
    },
    {
      "key": "2021122211435920900_R59",
      "doi-asserted-by": "crossref",
      "first-page": "1320",
      "DOI": "10.1126/science.275.5304.1320",
      "article-title": "Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5",
      "volume": "275",
      "author": "Bergelson",
      "year": "1997",
      "journal-title": "Science"
    },
    {
      "key": "2021122211435920900_R60",
      "doi-asserted-by": "crossref",
      "first-page": "1497",
      "DOI": "10.1038/sj.gt.3301038",
      "article-title": "Considerations and challenges for the achievement of targeted gene delivery",
      "volume": "6",
      "author": "Curiel",
      "year": "1999",
      "journal-title": "Gene Ther"
    },
    {
      "key": "2021122211435920900_R61",
      "doi-asserted-by": "crossref",
      "first-page": "309",
      "DOI": "10.1016/0092-8674(93)90231-E",
      "article-title": "Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment",
      "volume": "73",
      "author": "Wickham",
      "year": "1993",
      "journal-title": "Cell"
    },
    {
      "key": "2021122211435920900_R62",
      "doi-asserted-by": "crossref",
      "first-page": "10219",
      "DOI": "10.1074/jbc.274.15.10219",
      "article-title": "Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia",
      "volume": "274",
      "author": "Walters",
      "year": "1999",
      "journal-title": "J Biol Chem"
    },
    {
      "key": "2021122211435920900_R63",
      "doi-asserted-by": "crossref",
      "first-page": "1570",
      "DOI": "10.1038/nbt1196-1570",
      "article-title": "Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types",
      "volume": "14",
      "author": "Wickham",
      "year": "1996",
      "journal-title": "Nat Biotechnol"
    },
    {
      "key": "2021122211435920900_R64",
      "doi-asserted-by": "crossref",
      "first-page": "6831",
      "DOI": "10.1128/jvi.70.10.6831-6838.1996",
      "article-title": "Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies",
      "volume": "70",
      "author": "Wickham",
      "year": "1996",
      "journal-title": "J Virol"
    },
    {
      "key": "2021122211435920900_R65",
      "doi-asserted-by": "crossref",
      "first-page": "8221",
      "DOI": "10.1128/jvi.71.11.8221-8229.1997",
      "article-title": "Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins",
      "volume": "71",
      "author": "Wickham",
      "year": "1997",
      "journal-title": "J Virol"
    },
    {
      "key": "2021122211435920900_R66",
      "doi-asserted-by": "crossref",
      "first-page": "816",
      "DOI": "10.1038/sj.cgt.7700174",
      "article-title": "Adenovirus as a gene therapy vector for hematopoietic cells",
      "volume": "7",
      "author": "Marini FC",
      "year": "2000",
      "journal-title": "Cancer Gene Ther"
    },
    {
      "key": "2021122211435920900_R67",
      "doi-asserted-by": "crossref",
      "first-page": "1568",
      "DOI": "10.1126/science.286.5444.1568",
      "article-title": "Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae",
      "volume": "286",
      "author": "Roelvink",
      "year": "1999",
      "journal-title": "Science"
    },
    {
      "key": "2021122211435920900_R68",
      "first-page": "660",
      "article-title": "Addition of a short peptide ligand to the adenovirus fiber protein",
      "volume": "2",
      "author": "Michael",
      "year": "1995",
      "journal-title": "Gene Ther"
    },
    {
      "key": "2021122211435920900_R69",
      "doi-asserted-by": "crossref",
      "first-page": "1601",
      "DOI": "10.1128/JVI.73.2.1601-1608.1999",
      "article-title": "A helper-independent adenovirus vector with E1, E3, and fiber deleted: structure and infectivity of fiberless particles",
      "volume": "73",
      "author": "Seggern",
      "year": "1999",
      "journal-title": "J Virol"
    },
    {
      "key": "2021122211435920900_R70",
      "doi-asserted-by": "crossref",
      "first-page": "6875",
      "DOI": "10.1128/JVI.74.15.6875-6884.2000",
      "article-title": "Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells",
      "volume": "74",
      "author": "Dmitriev",
      "year": "2000",
      "journal-title": "J Virol"
    },
    {
      "key": "2021122211435920900_R71",
      "doi-asserted-by": "crossref",
      "first-page": "4502",
      "DOI": "10.1128/jvi.70.7.4502-4508.1996",
      "article-title": "Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells",
      "volume": "70",
      "author": "Huang",
      "year": "1996",
      "journal-title": "J Virol"
    },
    {
      "key": "2021122211435920900_R72",
      "doi-asserted-by": "crossref",
      "first-page": "9706",
      "DOI": "10.1128/JVI.72.12.9706-9713.1998",
      "article-title": "An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism",
      "volume": "72",
      "author": "Dmitriev",
      "year": "1998",
      "journal-title": "J Virol"
    },
    {
      "key": "2021122211435920900_R73",
      "first-page": "2571",
      "article-title": "Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector",
      "volume": "5",
      "author": "Kasono",
      "year": "1999",
      "journal-title": "Clin Cancer Res"
    },
    {
      "key": "2021122211435920900_R74",
      "doi-asserted-by": "crossref",
      "first-page": "227",
      "DOI": "10.1006/gyno.1999.5432",
      "article-title": "An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches",
      "volume": "74",
      "author": "Vanderkwaak",
      "year": "1999",
      "journal-title": "Gynecol Oncol"
    },
    {
      "key": "2021122211435920900_R75",
      "doi-asserted-by": "crossref",
      "first-page": "437",
      "DOI": "10.1038/sj.cgt.7700074",
      "article-title": "Polycations and cationic lipids enhance adenovirus transduction and transgene expression in tumor cells",
      "volume": "6",
      "author": "Clark",
      "year": "1999",
      "journal-title": "Cancer Gene Ther"
    },
    {
      "key": "2021122211435920900_R76",
      "doi-asserted-by": "crossref",
      "first-page": "1875",
      "DOI": "10.1089/10430349950017554",
      "article-title": "Recombinant adenoviral vector-lipofectAMINE complex for gene transduction into human T lymphocytes",
      "volume": "10",
      "author": "Di Nicola",
      "year": "1999",
      "journal-title": "Hum Gene Ther"
    },
    {
      "key": "2021122211435920900_R77",
      "doi-asserted-by": "crossref",
      "first-page": "1600",
      "DOI": "10.1038/sj.gt.3300987",
      "article-title": "Use of protamine to augment adenovirus-mediated cancer gene therapy",
      "volume": "6",
      "author": "Lanuti",
      "year": "1999",
      "journal-title": "Gene Ther"
    },
    {
      "key": "2021122211435920900_R78",
      "doi-asserted-by": "crossref",
      "first-page": "158",
      "DOI": "10.1111/j.1749-6632.1999.tb09409.x",
      "article-title": "Strategies to adapt adenoviral vectors for targeted delivery",
      "volume": "886",
      "author": "Curiel",
      "year": "1999",
      "journal-title": "Ann N Y Acad Sci"
    },
    {
      "key": "2021122211435920900_R79",
      "doi-asserted-by": "crossref",
      "first-page": "110",
      "DOI": "10.1038/sj.gt.3301115",
      "article-title": "Targeting adenovirus",
      "volume": "7",
      "author": "Wickham",
      "year": "2000",
      "journal-title": "Gene Ther"
    },
    {
      "key": "2021122211435920900_R80",
      "doi-asserted-by": "crossref",
      "first-page": "1565",
      "DOI": "10.1038/sj.gt.3300995",
      "article-title": "Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration",
      "volume": "6",
      "author": "Parks",
      "year": "1999",
      "journal-title": "Gene Ther"
    },
    {
      "key": "2021122211435920900_R81",
      "doi-asserted-by": "crossref",
      "first-page": "881",
      "DOI": "10.1089/hum.1995.6.7-881",
      "article-title": "Transcriptional regulatory sequences of carcinoembryonic antigen: identification and use with cytosine deaminase for tumor-specific gene therapy",
      "volume": "6",
      "author": "Richards",
      "year": "1995",
      "journal-title": "Hum Gene Ther"
    },
    {
      "key": "2021122211435920900_R82",
      "first-page": "2136",
      "article-title": "Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines",
      "volume": "59",
      "author": "Spitzweg",
      "year": "1999",
      "journal-title": "Cancer Res"
    },
    {
      "key": "2021122211435920900_R83",
      "doi-asserted-by": "crossref",
      "first-page": "10149",
      "DOI": "10.1073/pnas.89.21.10149",
      "article-title": "Ionizing radiation activates transcription of the EGR1 gene via CArG elements",
      "volume": "89",
      "author": "Datta",
      "year": "1992",
      "journal-title": "Proc Natl Acad Sci USA"
    },
    {
      "key": "2021122211435920900_R84",
      "first-page": "4266",
      "article-title": "Gene therapy targeted by radiation preferentially radiosensitizes tumor cells",
      "volume": "54",
      "author": "Weichselbaum",
      "year": "1994",
      "journal-title": "Cancer Res"
    },
    {
      "key": "2021122211435920900_R85",
      "doi-asserted-by": "crossref",
      "first-page": "1513",
      "DOI": "10.1016/S0360-3016(00)00788-4",
      "article-title": "Enhancement of radiotherapy by hyperthermia-regulated gene therapy",
      "volume": "48",
      "author": "Lohr",
      "year": "2000",
      "journal-title": "Int J Radiat Oncol Biol Phys"
    },
    {
      "key": "2021122211435920900_R86",
      "doi-asserted-by": "crossref",
      "first-page": "1624",
      "DOI": "10.1038/sj.gt.3301296",
      "article-title": "Transcriptionally active drugs improve adenovirus vector performance in vitro and in vivo",
      "volume": "7",
      "author": "Gaetano",
      "year": "2000",
      "journal-title": "Gene Ther"
    },
    {
      "key": "2021122211435920900_R87",
      "doi-asserted-by": "crossref",
      "first-page": "148",
      "DOI": "10.1016/S0959-437X(99)80022-7",
      "article-title": "Chromatin-modifying and -remodeling complexes",
      "volume": "9",
      "author": "Kornberg",
      "year": "1999",
      "journal-title": "Curr Opin Genet Dev"
    },
    {
      "key": "2021122211435920900_R88",
      "doi-asserted-by": "crossref",
      "first-page": "140",
      "DOI": "10.1016/S0959-437X(99)80021-5",
      "article-title": "Coactivator and corepressor complexes in nuclear receptor function",
      "volume": "9",
      "author": "Xu",
      "year": "1999",
      "journal-title": "Curr Opin Genet Dev"
    },
    {
      "key": "2021122211435920900_R89",
      "doi-asserted-by": "crossref",
      "first-page": "4241",
      "DOI": "10.1128/jvi.68.7.4241-4250.1994",
      "article-title": "Characterization of replication-competent retroviruses from nonhuman primates with virus-induced T-cell lymphomas and observations regarding the mechanism of oncogenesis",
      "volume": "68",
      "author": "Vanin",
      "year": "1994",
      "journal-title": "J Virol"
    },
    {
      "key": "2021122211435920900_R90",
      "doi-asserted-by": "crossref",
      "first-page": "919",
      "DOI": "10.1089/10430340050015536",
      "article-title": "Human gene marker/therapy clinical protocols",
      "volume": "11",
      "author": "Rosenberg",
      "year": "2000",
      "journal-title": "Hum Gene Ther"
    },
    {
      "key": "2021122211435920900_R91",
      "first-page": "4239",
      "article-title": "Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection",
      "volume": "10",
      "author": "Miller",
      "year": "1990",
      "journal-title": "Mol Cell Biol"
    },
    {
      "key": "2021122211435920900_R92",
      "doi-asserted-by": "crossref",
      "first-page": "1719",
      "DOI": "10.1126/science.276.5319.1719",
      "article-title": "HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia",
      "volume": "276",
      "author": "Bonini",
      "year": "1997",
      "journal-title": "Science"
    },
    {
      "key": "2021122211435920900_R93",
      "doi-asserted-by": "crossref",
      "first-page": "61",
      "DOI": "10.1006/mthe.2000.0225",
      "article-title": "Herpesvirus-mediated systemic delivery of nerve growth factor",
      "volume": "3",
      "author": "Wolfe",
      "year": "2001",
      "journal-title": "Mol Ther"
    },
    {
      "key": "2021122211435920900_R94",
      "doi-asserted-by": "crossref",
      "first-page": "347",
      "DOI": "10.1016/S1359-6446(01)01713-5",
      "article-title": "Multi-modal combination gene therapy for malignant glioma using replication-defective HSV vectors",
      "volume": "6",
      "author": "Burton",
      "year": "2001",
      "journal-title": "Drug Discov Today"
    },
    {
      "key": "2021122211435920900_R95",
      "doi-asserted-by": "crossref",
      "first-page": "34",
      "DOI": "10.1006/exnr.1999.7158",
      "article-title": "Engineering herpes simplex virus vectors for CNS applications",
      "volume": "159",
      "author": "Wolfe",
      "year": "1999",
      "journal-title": "Exp Neurol"
    },
    {
      "key": "2021122211435920900_R96",
      "doi-asserted-by": "crossref",
      "first-page": "4078",
      "DOI": "10.1073/pnas.96.7.4078",
      "article-title": "Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo",
      "volume": "96",
      "author": "Yamada",
      "year": "1999",
      "journal-title": "Proc Natl Acad Sci USA"
    },
    {
      "key": "2021122211435920900_R97",
      "doi-asserted-by": "crossref",
      "first-page": "743",
      "DOI": "10.1016/S0076-6879(00)16760-6",
      "article-title": "Production and purification of recombinant adeno-associated virus",
      "volume": "316",
      "author": "Hauswirth",
      "year": "2000",
      "journal-title": "Methods Enzymol"
    },
    {
      "key": "2021122211435920900_R98",
      "doi-asserted-by": "crossref",
      "first-page": "1031",
      "DOI": "10.1089/10430349950018427",
      "article-title": "Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses",
      "volume": "10",
      "author": "Clark",
      "year": "1999",
      "journal-title": "Hum Gene Ther"
    },
    {
      "key": "2021122211435920900_R99",
      "doi-asserted-by": "crossref",
      "first-page": "293",
      "DOI": "10.1038/sj.gt.3300807",
      "article-title": "Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus",
      "volume": "6",
      "author": "Liu",
      "year": "1999",
      "journal-title": "Gene Ther"
    },
    {
      "key": "2021122211435920900_R100",
      "doi-asserted-by": "crossref",
      "first-page": "6716",
      "DOI": "10.1073/pnas.97.12.6716",
      "article-title": "Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy",
      "volume": "97",
      "author": "Yan",
      "year": "2000",
      "journal-title": "Proc Natl Acad Sci USA"
    },
    {
      "key": "2021122211435920900_R101",
      "doi-asserted-by": "crossref",
      "first-page": "599",
      "DOI": "10.1038/75087",
      "article-title": "Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization",
      "volume": "6",
      "author": "Sun",
      "year": "2000",
      "journal-title": "Nat Med"
    },
    {
      "key": "2021122211435920900_R102",
      "doi-asserted-by": "crossref",
      "first-page": "266",
      "DOI": "10.1097/00005537-199902000-00017",
      "article-title": "Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus",
      "volume": "109",
      "author": "Wagner",
      "year": "1999",
      "journal-title": "Laryngoscope"
    },
    {
      "key": "2021122211435920900_R103",
      "doi-asserted-by": "crossref",
      "first-page": "7812",
      "DOI": "10.1128/JVI.73.9.7812-7816.1999",
      "article-title": "Rescue from photoreceptor degeneration in the rd mouse by human immunodeficiency virus vector-mediated gene transfer",
      "volume": "73",
      "author": "Takahashi",
      "year": "1999",
      "journal-title": "J Virol"
    },
    {
      "key": "2021122211435920900_R104",
      "doi-asserted-by": "crossref",
      "first-page": "49",
      "DOI": "10.1038/71673",
      "article-title": "Efficient lentiviral transduction of liver requires cell cycling in vivo",
      "volume": "24",
      "author": "Park",
      "year": "2000",
      "journal-title": "Nat Genet"
    },
    {
      "key": "2021122211435920900_R105",
      "doi-asserted-by": "crossref",
      "first-page": "1173",
      "DOI": "10.1182/blood.V96.3.1173.015k34_1173_1176",
      "article-title": "Therapeutic levels of human factor VIII and IX using HIV-1-based lentiviral vectors in mouse liver",
      "volume": "96",
      "author": "Park",
      "year": "2000",
      "journal-title": "Blood"
    },
    {
      "key": "2021122211435920900_R106",
      "doi-asserted-by": "crossref",
      "first-page": "314",
      "DOI": "10.1038/ng1197-314",
      "article-title": "Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors",
      "volume": "17",
      "author": "Kafri",
      "year": "1997",
      "journal-title": "Nat Genet"
    },
    {
      "key": "2021122211435920900_R107",
      "doi-asserted-by": "crossref",
      "first-page": "6641",
      "DOI": "10.1128/jvi.71.9.6641-6649.1997",
      "article-title": "Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector",
      "volume": "71",
      "author": "Blomer",
      "year": "1997",
      "journal-title": "J Virol"
    }
  ],
  "container-title": "The Oncologist",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.7-1-46",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://onlinelibrary.wiley.com/doi/full-xml/10.1634/theoncologist.7-1-46",
      "content-type": "application/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://academic.oup.com/oncolo/article-pdf/7/1/46/41838475/oncolo_7_1_46.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "syndication"
    },
    {
      "URL": "https://academic.oup.com/oncolo/article-pdf/7/1/46/41838475/oncolo_7_1_46.pdf",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2024,
        12,
        18
      ]
    ],
    "date-time": "2024-12-18T10:36:03Z",
    "timestamp": 1734518163000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://academic.oup.com/oncolo/article/7/1/46/6387757"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2002,
        2,
        1
      ]
    ]
  },
  "references-count": 107,
  "journal-issue": {
    "issue": "1",
    "published-online": {
      "date-parts": [
        [
          2002,
          2,
          1
        ]
      ]
    },
    "published-print": {
      "date-parts": [
        [
          2002,
          2,
          1
        ]
      ]
    }
  },
  "URL": "http://dx.doi.org/10.1634/theoncologist.7-1-46",
  "relation": {},
  "ISSN": [
    "1083-7159",
    "1549-490X"
  ],
  "subject": [],
  "published-other": {
    "date-parts": [
      [
        2002,
        2,
        1
      ]
    ]
  },
  "published": {
    "date-parts": [
      [
        2002,
        2,
        1
      ]
    ]
  }
}